Qiming U.S. Ventures Management as of Sept. 30, 2024
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 6 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tourmaline Bio (TRML) | 37.1 | $19M | 742k | 25.71 | |
| Jasper Therapeutics Com New (JSPR) | 34.0 | $18M | 929k | 18.81 | |
| Korro Bio (KRRO) | 23.9 | $12M | 368k | 33.42 | |
| Hillevax | 1.9 | $984k | 559k | 1.76 | |
| Ventyx Biosciences (VTYX) | 1.7 | $899k | 412k | 2.18 | |
| Kezar Life Sciences | 1.2 | $638k | 829k | 0.77 |
